Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04081805 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

LASER and Radiofrequency for Treatment of Vaginal Vulvar Atrophy (VVA) in Women Treated for Breast Cancer (EPMLARF-arm2)

Study acronym: EPMLARF
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 24, 2025 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Sep 2024 to Sep 2025
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v4
  2. Primary completion date: Sep 2021 to Sep 2024
    • Study completion date: Sep 2023 to Sep 2025
    v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a randomized controlled trial to evaluate the use of LASER, Micro Ablative radiofrequency and topic promestriene to treat symptoms of vulvovaginal atrophy of women treated for breast cancer.
Trial Details
NCT Number NCT04081805
Lead Sponsor Federal University of São Paulo
Collaborators: Fundação de Amparo à Pesquisa do Estado de São Paulo
Conditions
(from sponsor)		 Vaginal Atrophy, Vulva; Atrophy, Breast Cancer
Related terms Atrophy, Breast Neoplasms
Enrollment 195 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov